限制性液体复苏联合早期镇静镇痛对感染性休克患者心肌损伤标志物动态变化的影响

Impact of limited fluid resuscitation combined with early sedation and analgesia on dynamic changes of myocardial damage markers in patients with septic shock

  • 摘要: 目的 探究限制性液体复苏(LFR)联合早期镇静镇痛对感染性休克(SS)患者心肌损伤标志物动态变化的影响。方法 选择2022年1月-2024年12月于常熟市中医院治疗的150例SS患者为研究对象。根据随机数字表法,分为研究组(LFR联合早期镇静镇痛)和对照组(充分液体复苏联合早期镇静镇痛),每组75例。比较两组治疗前及治疗24、48、72 h后急性生理学及慢性健康状况评分系统Ⅱ(APACHE Ⅱ)、序贯器官衰竭评估(SOFA)、血流动力学指标血浆黏度(PV)、红细胞压积(HCT)、纤维蛋白原(FIB)、炎症因子水平白细胞介素6(IL-6)、IL-1、肿瘤坏死因子-α(TNF-α)、C-反应蛋白(CRP)、心肌损伤指标心肌肌钙蛋白I(cTnI)、肌酸激酶同工酶(CK-MB)、脑钠肽(BNP)水平变化。结果 与对照组(76.00%)相比,研究组(89.33%)患者的临床总有效率更高(P<0.05)。两组不同时间点APACHE Ⅱ评分、SOFA评分、PV、HCT、FIB、IL-6、IL-1、TNF-α、CRP、cTnI、CK-MB、BNP比较,差异均有统计学意义(均P<0.05)。研究组治疗后APACHE Ⅱ评分、SOFA评分、PV、HCT、FIB、IL-6、IL-1、TNF-α、CRP、cTnI、CK-MB、BNP均低于对照组(均P<0.05)。结论 LFR联合早期镇静镇痛能显著改善SS患者的临床疗效及血流动力学反应,降低APACHE Ⅱ和SOFA评分,减少心肌损伤标志物及炎症因子水平。

     

    Abstract: OBJECTIVE To explore the effect of limited fluid resuscitation (LFR) combined with early sedation and analgesia on dynamic changes of myocardial injury markers of the patients with septic shock (SS). METHODS A total of 150 patients with SS who were treated in Changshu Hospital of Traditional Chinese Medicine from Jan. 2022 to Dec. 2024 were recruited as the research subjects and were randomly divided into the study group (LFR combined with early sedation and analgesia) and the control group (adequate fluid resuscitation combined with early sedation and analgesia), with 75 cases in each group. The Acute Physiology and Chronic Health Evaluation II (APACHE II) score, sequential organ failure assessment (SOFA), hemodynamics indicatorsplasma viscosity (PV), hematocrit (HCT), and fibrinogen (FIB), inflammatory factorsinterleukin-6 (IL-6), IL-1, tumor necrosis factor-α (TNF-α), and C-reactive protein (CRP), and myocardial injury indicatorscardiac troponin I (cTnI), creatine kinase isoenzyme (CK-MB), brain natriuretic peptide (BNP)were observed and compared between the two groups before the treatment and after the treatment for 24, 48, and 72 hours. RESULTS The total effective rate of the study group was 89.33%, higher than 76.00% of the control group(P<0.05). There were significant differences in APACHE II score, SOFA score, PV, HCT, FIB, IL-6, IL-1, TNF-α, CRP, cTnI, CK-MB and BNP between the two groups at the time points (all P<0.05). The APACHE II score, SOFA score, PV, HCT, FIB, IL-6, IL-1, TNF-α, CRP, cTnI, CK-MB and BNP were lower in the study group than in the control group after the treatment (all P<0.05). CONCLUSIONS LFR combined with early sedation and analgesia can remarkably improve the clinical therapeutic effect and hemodynamic reactions of the patients with SS, reduce the scores of APACHE II and SOFA, and decrease the levels of myocardial injury indictors and inflammatory factors.

     

/

返回文章
返回